marasa shan sigari maganin kansar huhu

Ciwon daji na huhu a cikin mutanen da ba su taɓa shan taba yana ba da ƙalubale na musamman da hanyoyin magani. Duk da yake shan taba sanannen abu ne mai haɗari, wani yanki mai mahimmanci na cututtukan huhu na huhu yana faruwa a cikin mutanen da ba su da tarihin amfani da taba. Wannan labarin yana bincika abubuwan da suka bambanta marasa shan sigari maganin kansar huhu, ciki har da ganewar asali, zaɓuɓɓukan magani, da kuma ci gaba da bincike. Bincike da Nau'in Ciwon daji na huhu a cikin Masu shan taba Binciken ciwon huhu a cikin wadanda ba su taba shan taba ba sau da yawa suna ba da bambanci fiye da masu shan taba. Yana da mahimmanci a fahimci abubuwan ganowa da takamaiman nau'ikan cutar kansar huhu da ke yaɗuwa a cikin wannan yawan. Kalubalen Gano FarkoDaya daga cikin manyan ƙalubale shine rashin zato. Saboda ciwon huhu na huhu yana hade da shan taba, ƙila ba za a yi la'akari da shi a matsayin mai sauƙi a cikin masu shan taba ba, yana haifar da jinkirin ganewar asali. Alamun na iya zama m ko dangana ga wasu yanayi. Dabarun ganowa da wuri kamar gwajin cutar kansar huhu ta hanyar amfani da ƙananan CT scans yawanci ba a ba da shawarar ga jama'ar jama'ar da ba su taɓa shan taba ba, suna ƙara rikitar da farkon ganewar asali.Nau'in Ciwon Huhu na Jama'a a Ba Masu shan taba Yayin da masu shan taba suka fi saurin kamuwa da ciwon daji na huhu da ƙananan ƙwayoyin huhu, ba masu shan taba suna iya haifar da adenocarcinoma ba. Adenocarcinoma sau da yawa yana tasowa a cikin yankunan waje na huhu, yana sa ya fi dacewa a gano shi kafin yaduwa. Sauran, nau'ikan da ba su da yawa kuma na iya faruwa. Cibiyar Binciken Ciwon daji ta Shandong Baofa (https://baofahospital.com) An sadaukar da mu don ƙara fahimtar nau'o'in ciwon daji na huhu da kuma inganta hanyoyin bincike. Zaɓuɓɓukan Magani don marasa shan taba Lung Cancer Magani hanyoyin magance ciwon huhu a cikin taba shan taba sau da yawa ana keɓance shi da takamaiman nau'i da mataki na ciwon daji, da kuma lafiyar mutum gabaɗaya.Tashin tiyata na tiyata, wanda ya haɗa da cirewar ƙwayar huhu da wuri, zai iya zama zaɓi na curstage na ƙwayar cuta. Ana ƙara amfani da fasaha kaɗan na ɓarna kamar aikin tiyata na thoracoscopic na bidiyo (VATS) don rage lokacin dawowa da inganta sakamako.Radiation TherapyRadiation far yana amfani da haskoki mai ƙarfi don kashe ƙwayoyin cutar kansa. Ana iya amfani da shi azaman jiyya na farko ga marasa lafiya waɗanda basu dace da tiyata ba, ko azaman maganin adjuvant bayan tiyata don kawar da sauran ƙwayoyin cutar kansa. Dabaru irin su stereotactic body radiation therapy (SBRT) suna isar da radiation mai da hankali sosai ga ƙari yayin da rage lalacewar nama mai lafiya.ChemotherapyChemotherapy ya ƙunshi amfani da kwayoyi don kashe ƙwayoyin kansa a cikin jiki. Ana amfani da shi sau da yawa don ƙarin ci gaba na ciwon huhu na huhu ko a hade tare da tiyata ko maganin radiation. Ƙayyadaddun tsarin magani na chemotherapy ya bambanta dangane da nau'in ciwon daji na huhu da kuma lafiyar majiyyaci gabaɗaya. Maganin da aka yi niyya ya mayar da hankali kan takamaiman ƙwayoyin cuta ko hanyoyin da ke cikin haɓakar ciwon daji da yaduwa. Yawancin masu shan taba da adenocarcinoma suna da maye gurbi, kamar EGFR, ALK, ROS1, ko BRAF. Gano waɗannan maye gurbi yana bawa likitoci damar rubuta hanyoyin da aka yi niyya waɗanda ke hana ayyukan waɗannan sunadarai da suka canza, wanda ke haifar da ingantattun sakamako.ImmunotherapyImmunotherapy yana haɓaka tsarin garkuwar jiki don yaƙar kansa. Masu hana abubuwan dubawa, irin su PD-1 da masu hana PD-L1, wani nau'in rigakafin rigakafi ne wanda ya nuna alƙawarin magance wasu nau'ikan kansar huhu, gami da waɗanda aka samu a cikin waɗanda ba su taɓa shan taba ba. Amfanin immunotherapy ya dogara da dalilai daban-daban, ciki har da kasancewar takamaiman masu nazarin halittu.Muhimmancin Gwajin Halitta a cikin marasa shan taba huhu Cancer GwajinGenetic yana da mahimmanci a gudanar da marasa shan sigari ciwon huhu. Gano takamaiman maye gurbi yana bawa likitoci damar keɓance shirye-shiryen jiyya da zaɓin hanyoyin da aka yi niyya mafi inganci ko rigakafin rigakafi.Gwargwadon Halittar HalittaDa yawa maye gurbi a cikin ciwon huhu a cikin waɗanda ba su taɓa shan taba ba, ciki har da: EGFR (Epidermal Growth Factor Receptor) maye gurbin ALK (Anaplastic Lymphoma Kinase1) fusions fusions. don yin amfani da magungunan da aka yi niyya wanda ke hana ayyukan sunadarai masu maye gurbin, wanda ke haifar da ingantattun sakamako da kuma tsawon rayuwa.Amfanin Jiyya na Keɓaɓɓen Jiyya bisa ga gwajin kwayoyin halitta yana ba da damar ingantaccen tsarin kula da ciwon daji. Ta hanyar kai hari kan takamaiman direbobin kwayoyin cutar kansa, likitoci na iya rage illar illa da inganta rayuwar marasa lafiya gaba ɗaya. The Shandong Baofa Cibiyar Nazarin Ciwon daji Ya jaddada keɓaɓɓen magani a cikin maganin cutar kansa. Gwajin asibiti da ci gaba da bincike Gwajin asibiti na taka muhimmiyar rawa wajen haɓaka maganin cutar kansa. marasa shan sigari ciwon huhu. Waɗannan karatun suna kimanta sabbin hanyoyin kwantar da hankali, haɗaɗɗun jiyya, da dabarun bincike.Neman gwaji na asibiti Marasa lafiya masu sha'awar shiga gwaji na asibiti na iya nemo gwaji ta hanyar tushe masu daraja, kamar: Cibiyar Ciwon daji ta ƙasa (NCI): https://www.cancer.gov/about-cancer/treatment/clinical-trialsClinicalTrials.gov: https://clinicaltrials.gov/Wuraren Bincike Ƙoƙarin bincike na yanzu yana mai da hankali kan: Haɓaka sabbin hanyoyin kwantar da hankali don takamaiman maye gurbi na ƙwayoyin cuta Inganta ingancin immunotherapyKayyade sabbin alamomin halittu don ganowa da wuri da amsawar jiyya Fahimtar ilimin halitta na musamman na cutar kansar huhu a cikin masu shan taba Hasashen da Rates Tsira. marasa shan sigari maganin kansar huhu ya bambanta dangane da matakin ciwon daji a ganewar asali, takamaiman nau'in ciwon daji, da kuma lafiyar mutum gaba ɗaya. Gabaɗaya, ba a taɓa taɓa masu shan taba da ciwon huhu ba suna da kyakkyawan hasashen fiye da masu shan sigari, musamman idan suna da ciwace-ciwacen ƙwayar cuta tare da maye gurbi da aka yi niyya.Abubuwan da ke shafar hasasheAbubuwan da za su iya yin tasiri kan hasashen sun haɗa da: Matsayin ciwon daji a gano nau'in kansar huhuBabban maye gurbi na ƙwayoyin cuta Gabaɗaya kiwon lafiya da dacewa da rayuwa ta musamman don tsira da shan taba Ciwon daji na huhu ya bambanta a ko'ina cikin karatu, wani binciken 2020 da aka buga a cikin *Journal of Thoracic Oncology* ya gano cewa ba su taɓa shan taba tare da ci gaban adenocarcinoma da maye gurbi na EGFR yana da matsakaicin rayuwa na tsawon watanni 38.6 tare da maganin da aka yi niyya, idan aka kwatanta da watanni 26.7 ga masu shan taba tare da maye gurbi iri ɗaya da aka yi amfani da su tare da chemotherapy. 1 Rukuni na Jiyya Matsakaici Gabaɗaya Rayuwa (Wata- Watanni) Ba Masu shan Sigari tare da EGFR+ Advanced Adenocarcinoma Therapy 38.6 Masu shan taba tare da EGFR+ Advanced Adenocarcinoma Chemotherapy 26.7 Source: 1. Jaridar Thoracic Oncology, 2020KammalawaMaganin ciwon huhu mara shan taba filin ne mai tasowa tare da haɓaka dama don keɓaɓɓen hanyoyin warkewa masu inganci. Fahimtar takamaiman halaye na kansar huhu a cikin waɗanda ba su taɓa shan taba ba, gami da nau'ikan ciwon daji da maye gurbi na gama gari, yana da mahimmanci don haɓaka sakamakon jiyya. Ci gaba da bincike da gwaje-gwaje na asibiti suna da mahimmanci don ci gaba da kulawa da mutanen da aka gano da ciwon huhu da ba su taɓa shan taba ba. Neman ƙwararrun shawarwarin likita da bincika zaɓuɓɓukan magani da ake da su sune matakai masu mahimmanci wajen sarrafa wannan yanayin.